BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Synthetic Biologics to Report Third Quarter 2017 Operational Highlights and Financial Results on November 1, 2017

  Synthetic Biologics announced today that the Company intends to release its operational highlights and financial results for the quarter ended September 30, 2017 on Wednesday, November 1, 2017, and to host a conference call the same day at 4:30 p.m. EDT.

  October 25, 2017

   · 

  1 min read
• Business

  Compugen Third Quarter 2017 Conference Call Scheduled for Tuesday, November 7, 2017 at 10:00 AM ET

  Compugen announced today that the Company will release its third quarter financial results on Tuesday, November 7, 2017 before the U.S. financial markets open.

  October 25, 2017

   · 

  1 min read
• BioMidwest

  Zimmer Biomet Announces U.S. Launch of Vitality+ and Vital Spinal Fixation Systems

  Zimmer Biomet today announced the official launch of its Vitality+ and Vital Spinal Fixation Systems in the United States at the 2017 NASS Annual Meeting.

  October 25, 2017

   · 

  7 min read
• Drug Development

  Alopexx Completes First-in-Man Trial of its Novel, Broad-Spectrum Anti-Microbial Vaccine

  Alopexx today announced that it has completed a Phase I clinical trial with AV0328, a vaccine targeting the broadly expressed microbial antigen, poly-N-acetyl glucosamine.

  October 25, 2017

   · 

  3 min read
• FDA

  CFDA Approves ORTHO VISION Platform for Transfusion Medicine Labs

  Ortho Clinical Diagnostics today announced that its ORTHO VISION Platform of fully automated blood analyzers for low-, mid- and high-volume transfusion medicine laboratories has received approval by the CFDA.

  October 25, 2017

   · 

  3 min read
• Business

  China Biologic Products to Report Third Quarter of 2017 Financial Results

  China Biologic Products today announced that the Company plans to release third quarter of 2017 financial results on Wednesday, November 1, 2017 after the market closes.

  October 25, 2017

   · 

  2 min read
• Business

  Tekni-Plex Promotes Glenn Fish to Chief Operating Officer

  Tekni-Plex announces the promotion of Glenn Fish to COO.

  October 25, 2017

   · 

  2 min read
• Business

  Cerapedics Announces Appointment of Doug Kohrs to Board of Directors and Names Antony Koblish Board Chair

  CeraPedics today announced the appointment of Doug Kohrs to the company’s board of directors and the appointment of Antony Koblish as board chair.

  October 25, 2017

   · 

  3 min read
• 

  Policy

  Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for INVELTYSTM (KPI-121 1%)

  The drug is a topical twice-a-day product candidate for the treatment of inflammation and pain in patients who have undergone ocular surgery.

  October 25, 2017

   · 

  7 min read
• Business

  RiverVest Venture Partners Expands Scientific Advisory Board

  RiverVest Venture Partners announced today that Ronald T. Borchardt, Ph.D. and Jared Rutter, Ph.D. have joined the life science venture capital firm’s Scientific Advisory Board.

  October 25, 2017

   · 

  4 min read